Résumé
About the Role
Your responsibilities include, but not limited to:
Develop Strategy for a Cardio Renal or Metabolic portfolio pillar and contribute to overall TA strategy
Define and drive mid-and-long term portfolio strategy, goals, strategic objectives and leadership aspiration within TA and DAs in collaboration with other functions within Strategy & Growth (S&G), and across US and International commercial, Biomedical Research, and Development units
Support the Therapeutic Area Leadership team (TAL) as the Enterprise strategic body that owns the TA Strategy and reviews all programs at Toll Gate transitions (from drug candidate to SDP)
Lead strategy revisions and updates and orchestrate stakeholder alignment as needed, e.g., due to internal or external market events.
Identify potential pipeline gaps and make recommendations to address with other S&G functions, US, International, Biomedical Research, and Development
Commercial lead on external evaluations for BD&L and acquisitions, inception to deal close. Developing evaluations (across all phase products) based a thorough understanding of the TA, insights developed and tested externally using secondary analytics, PMR and CI.
Commercial lead on the early phase project teams (from drug candidate to Phase 3). Responsible for p3 programs transition to US and International Markets,
Responsible for forecast and other commercial models’ development and alignment with key markets
Collaborate closely with key stakeholders (e.g., US, International, Biomedical Research, Development, and engage other functions such as Value & Access and US Market Access) to facilitate port-folio decision making in the context of our goal of becoming a top 5 Pharma player in the US while maintaining our international leadership.
Key Requirements:
- Advanced degree (PhD, MD cardiologist or internal medicine preferred) or equivalent experience in life science/healthcare; MBA.
- Significant experience gained in Pharma Industry with a strong Scientific or medical background
- Significant BD&L and or M&A deal and evaluation experience (agile in assimilating technical and medical data, financial modelling (forecasting, P&L), conducting, commissioning, analyzing primary and secondary research)
- Demonstrated Consulting experience & C-suite presentation skills, written and oral
- Demonstrated Therapeutic Area (TA) knowledge and experience in Cardio Renal or Metabolic (or track record to acquire required TA expertise effectively and rapidly)
- Experience of strategy development and asset shaping early in lifecycle.
- Highly agile having the capacity to manage several strategic Disease Areas (Das) within a TA and multiple programs internal and external.
- Highly analytical with the ability to lead and thrive in high challenging environment.
- Proficiency in English required. (spoken and written).
- Extensive US market experience
- Effective and persuasive communicator with strong presentation, communication (both written and verbal), influencing and negotiation skills.
- Travel: ability to travel domestically and internationally, to be determined based on business needs
Why Novartis: Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting and inspiring each other. Combining to achieve breakthroughs that change patients’ lives. Ready to create a brighter future together? https://www.novartis.com/about/strategy/people-and-culture
Join our Novartis Network: Not the right Novartis role for you? Sign up to our talent community to stay connected and learn about suitable career opportunities as soon as they come up: https://talentnetwork.novartis.com/network